Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer

Use of proteomic strategies to identify a risk classifier that estimates probability of distant recurrence in early-stage hormone receptor (HR)-positive breast cancer is relevant to physiological cellular function and therefore to intrinsic tumor biology. We used a 298-sample retrospective training...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramkumar, Charusheila, Buturovic, Ljubomir, Malpani, Sukriti, Kumar Attuluri, Arun, Basavaraj, Chetana, Prakash, Chandra, Madhav, Lekshmi, Doval, Dinesh Chandra, Mehta, Anurag, Bakre, Manjiri M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066801/
https://www.ncbi.nlm.nih.gov/pubmed/30083053
http://dx.doi.org/10.1177/1177271918789100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066801/
https://www.ncbi.nlm.nih.gov/pubmed/30083053
http://dx.doi.org/10.1177/1177271918789100

Ejemplares similares